elanco shareholder analysis
Ignore Weather Headlines, Investors Need This Pet Health Truth
In 2024, Elanco’s flea and tick product sales rose 12% as warmer months extended the parasite season. The hidden climate beta in Elanco’s portfolio means weather amplifies only certain segments while core therapeutics stay steady, giving savvy shareholders a clearer risk picture. Medical Disclaimer: This article is for